Literature DB >> 11118847

beta-Lactam susceptibility patterns and investigation of cephalosporin hydrolysing beta-lactamases of Gram-negative extraintestinal clinical isolates.

Z Gál1, D Szabó, P Kovács, F Hernádi, B Tóth-Martinez, F Rozgonyi.   

Abstract

Of more than 3500 isolates of enterobacteriaceae, 48-69% were resistant to aminopenicillins and 11-45% to amoxycillin+clavulanic acid. Resistance to second and third generation cephalosporins was present in 11-17 and 3-8% of Escherichia coli, 47-56 and 15-52% of Klebsiella-Enterobacter, 36-57 and 16-27% of Proteus, Providencia and Morganella isolates. Pseudomonas aeruginosa strains varied in their resistance to antipseudomonal beta-lactams. Isoelectric points, inhibitor profiles and substrate profiles of beta-lactamases extracted from representatives of the resistant strains indicated that the resistance was mainly due to the hyperproduction of chromosomally encoded AmpC beta-lactamases. This was confirmed by plasmid profile and PCR investigations. Extended-spectrum beta-lactamase and metallo-penicillinase producing strains were not found. One Pseudomonas maltophilia strain produced an oxacillinase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118847     DOI: 10.1016/s0924-8579(00)00190-4

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  Clinical pseudomonas aeruginosa: potential factors of pathogenicity and resistance to antimicrobials.

Authors:  A Hostacká; I Ciznár; L Slobodníkova; D Kotulová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.

Authors:  Balázs Ivády; Éva Kenesei; Péter Tóth-Heyn; Gabriella Kertész; Klára Tárkányi; Csaba Kassa; Enikő Ujhelyi; Borbála Mikos; Erzsébet Sápi; Krisztina Varga-Heier; Gábor Guóth; Dóra Szabó
Journal:  Infection       Date:  2015-11-06       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.